You’re warm, but that’s not exactly the answer to the question.
The FDA already has the authority to approve generic polysaccharide drugs (e.g. Lovenox) and generic polypeptide drugs (e.g. Copaxone) because these classes of drugs are regulated as small molecules.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”